RANKL inhibition: a new target of treating diabetes mellitus?
Baodi Xing(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuxiu Li(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 22
Related Papers
Insulin and liraglutide attenuate brain pathology in diabetic mice by enhancing the Wnt/β‑catenin signaling pathway
|Experimental and Therapeutic Medicine|2022|12